This is the authors' abstract. We don't add key points for this paper.
The unparalleled theoretical specific energy of lithium-sulfur (Li-S) batteries has attracted considerable research interest from within the battery community. However, most of the long cycling results attained thus far relies on using a large amount of electrolyte in the cell, which adversely affects the specific energy of Li-S batteries. This shortcoming originates from the low solubility of polysulfides in the electrolyte. Here, 1,3-dimethyl-2-imidazolidinone (DMI) is reported as a new high donor electrolyte for Li-S batteries. The high solubility of polysulfides in DMI and its activation of a new reaction route, which engages the sulfur radical (S₃ •- ), enables the efficient utilization of sulfur as reflected in the specific capacity of 1595 mAh g⁻¹ under lean electrolyte conditions of 5 μLelectrolyte mgsulfur ⁻¹ . Moreover, the addition of LiNO₃ stabilizes the lithium metal interface, thereby elevating the cycling performance to one of the highest known for high donor electrolytes in Li-S cells. These engineered high donor electrolytes are expected to advance Li-S batteries to cover a wide range of practical applications, particularly by incorporating established strategies to realize the reversibility of lithium metal electrodes.
No takes yet. Share an insight, caveat, or question.
Baek et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: